Published in J Endocrinol on July 01, 2002
The use of digit ratios as markers for perinatal androgen action. Reprod Biol Endocrinol (2006) 1.80
The role of steroids in follicular growth. Reprod Biol Endocrinol (2006) 1.36
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update (2008) 1.30
Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism (2008) 1.20
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun (2015) 1.14
Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod (2008) 1.10
Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun (2015) 1.09
Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol (2012) 1.07
Contributions of androgen and estrogen to fetal programming of ovarian dysfunction. Reprod Biol Endocrinol (2006) 1.01
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol (2007) 0.99
Neuroendocrine consequences of androgen excess in female rodents. Horm Behav (2008) 0.98
Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction (2011) 0.96
Prenatal exposure to stressful life events is associated with masculinized anogenital distance (AGD) in female infants. Physiol Behav (2013) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.93
Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord (2010) 0.93
Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am (2005) 0.93
Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PLoS One (2012) 0.93
The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS One (2011) 0.91
Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91
Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med (2014) 0.90
The exposome--exciting opportunities for discoveries in reproductive and perinatal epidemiology. Paediatr Perinat Epidemiol (2013) 0.90
The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques. Endocrinology (2008) 0.90
Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. J Physiol (2011) 0.90
The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol (2014) 0.88
What do we know about metabolic syndrome in adolescents with PCOS? J Turk Ger Gynecol Assoc (2014) 0.88
FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women. J Assist Reprod Genet (2011) 0.86
Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol (2012) 0.85
Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys. PLoS One (2012) 0.85
Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med (2013) 0.84
A comparison of anthropometric, metabolic, and reproductive characteristics of young adult women from opposite-sex and same-sex twin pairs. Front Endocrinol (Lausanne) (2014) 0.83
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril (2013) 0.82
Exposure of female macaques to Western-style diet with or without chronic T in vivo alters secondary follicle function during encapsulated 3-dimensional culture. Endocrinology (2014) 0.82
LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity. Int J Pediatr Endocrinol (2010) 0.81
Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries. Reproduction (2008) 0.81
Does vitamin D status correlate with clinical and biochemical features of polycystic ovarysyndrome in high school girls? Caspian J Intern Med (2014) 0.80
2D:4D ratio in children at familial high-risk for eating disorders: The role of prenatal testosterone exposure. Am J Hum Biol (2013) 0.80
The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size. J Clin Endocrinol Metab (2010) 0.80
Increased ovarian follicle atresia in obese Zucker rats is associated with enhanced expression of the forkhead transcription factor FOXO1. Med Mol Morphol (2009) 0.79
Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes. Clin Exp Immunol (2008) 0.79
Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys. Endocrinology (2014) 0.79
Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol (2016) 0.78
Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res (2012) 0.78
Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models. Front Neuroendocrinol (2014) 0.78
The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res (2012) 0.77
Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India. Indian J Endocrinol Metab (2014) 0.77
Does PCOS have developmental origins? Fertil Steril (2012) 0.77
The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria. Int J Fertil Steril (2011) 0.77
Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. J Assist Reprod Genet (2013) 0.77
Effects of resistin on porcine ovarian follicle steroidogenesis in prepubertal animals: an in vitro study. Reprod Biol Endocrinol (2013) 0.77
Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS). Endocrinology (2015) 0.76
Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity? PLoS One (2015) 0.76
Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol (2017) 0.75
Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS. Endocrinology (2016) 0.75
Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats. Int J Endocrinol Metab (2015) 0.75
The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus. Int J Reprod Med (2014) 0.75
Cryptotanshinone Regulates Androgen Synthesis through the ERK/c-Fos/CYP17 Pathway in Porcine Granulosa Cells. Evid Based Complement Alternat Med (2017) 0.75
Androgen Receptor in the Ovary Theca Cells Plays a Critical Role in Androgen-Induced Reproductive Dysfunction. Endocrinology (2016) 0.75
Androgen Stimulates Growth of Mouse Preantral Follicles In Vitro: Interaction With Follicle-Stimulating Hormone and With Growth Factors of the TGFβ Superfamily. Endocrinology (2017) 0.75
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) (1978) 2.91
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update (2005) 2.07
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet (1997) 1.91
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab (2009) 1.77
Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 1.76
Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol (1977) 1.65
Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1988) 1.62
Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) (1975) 1.61
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet (1994) 1.58
Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod (1993) 1.58
Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf) (1992) 1.57
Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update (1998) 1.46
Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab (1994) 1.44
Formation and early development of follicles in the polycystic ovary. Lancet (2003) 1.41
Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) (1976) 1.40
Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab (1998) 1.36
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1997) 1.34
Transplacental cardioversion of fetal supraventricular tachycardia with procainamide. N Engl J Med (1982) 1.33
Effects of follicle-stimulating hormone and serum substitution on the in-vitro growth of human ovarian follicles. Hum Reprod (1999) 1.24
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol (1998) 1.23
Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab (1998) 1.23
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol (1992) 1.22
Blood on the embryo transfer catheter is associated with decreased rates of embryo implantation and clinical pregnancy with the use of in vitro fertilization-embryo transfer. Fertil Steril (1998) 1.20
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) (1993) 1.18
Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab (2000) 1.18
Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab (1996) 1.18
Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet (1997) 1.17
Post-"pill" amenorrhoea--cause or coincidence? Br Med J (1977) 1.15
Embryo cryopreservation at the pronuclear stage and efficient embryo use optimizes the chance for a liveborn infant from a single oocyte retrieval. Fertil Steril (2000) 1.12
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia (2008) 1.12
Recurrent early miscarriage and polycystic ovaries. BMJ (1988) 1.11
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) (1990) 1.09
Endocrine aspects of bromocriptine therapy in Parkinsonism. J Neural Transm (1978) 1.08
Mechanical isolation and in vitro growth of preantral and small antral human follicles. Fertil Steril (1997) 1.05
Inferring biological mechanisms from spatial analysis: prediction of a local inhibitor in the ovary. Proc Natl Acad Sci U S A (2009) 1.05
Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod (2008) 1.05
Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer. Fertil Steril (1999) 1.04
Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours. Lancet (1977) 1.03
Therapy-orientated diagnosis of secondary amenorrhoea. Horm Res (1975) 1.02
Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab (1994) 1.01
Steroid responsiveness in phaeochromocytoma. Br Med J (1977) 1.01
Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab (1996) 1.01
Prolactin concentrations in patients with breast cancer. Br Med J (1974) 1.01
Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod (2011) 1.01
Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1987) 1.01
The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) (1993) 1.00
Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod (1995) 0.99
Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory follicles. Hum Reprod (1993) 0.99
Primary and secondary amenorrhoea. Br Med J (Clin Res Ed) (1987) 0.99
Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med (2013) 0.99
The catechol estrogens. J Steroid Biochem (1981) 0.98
Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int J Obes Relat Metab Disord (2003) 0.97
Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) (1989) 0.96
Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod (1991) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent. Gynecol Endocrinol (2003) 0.95
Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery. Clin Endocrinol (Oxf) (1976) 0.95
Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci (Lond) (1983) 0.94
Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol (1990) 0.94
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod (2004) 0.94
No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth. Diabetologia (2007) 0.93
A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion. Br J Obstet Gynaecol (1989) 0.92
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod (2012) 0.92
Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab (1995) 0.92
The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf) (2000) 0.91
A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. J Clin Endocrinol Metab (1999) 0.90
Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod (2004) 0.90
Pronuclear stage cryopreservation after intracytoplasmic sperm injection and conventional IVF: implications for timing of the freeze. Fertil Steril (1999) 0.90
Adipocyte biology in polycystic ovary syndrome. Mol Cell Endocrinol (2012) 0.90
Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders. Fertil Steril (1989) 0.89
Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. J Endocrinol (2000) 0.89
Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1995) 0.89
Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment. Lancet (1981) 0.89
In vitro maturation of oocytes. Br Med Bull (2000) 0.89
No association between insulin gene variation and adult metabolic phenotypes in a large Finnish birth cohort. Diabetologia (2005) 0.88
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) (1996) 0.88
Expression of insulin-like growth factor (IGF), IGF-binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries. J Clin Endocrinol Metab (1996) 0.88
Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J Endocrinol (1990) 0.88
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia (2007) 0.88
Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int J Obes (Lond) (2007) 0.87
The prevalence of polycystic ovaries in women with infertility. Hum Reprod (1999) 0.87
Hyperprolactinaemia. Clin Endocrinol Metab (1983) 0.87
Retroperitoneal endometriosis causing unilateral hip pain. Obstet Gynecol (2001) 0.87
False-positive Y-microdeletion result for a fertile male caused by an alteration under a PCR primer. Int J Androl (2002) 0.86
Letter: Prolactin studies, pituitary tumour, and reproductive function. Br Med J (1975) 0.86
Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin Endocrinol (Oxf) (1993) 0.86
Common problems in induction of ovulation. Baillieres Clin Obstet Gynaecol (1990) 0.86
Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis. Hum Reprod (2000) 0.85
Reduced frequency of luteinizing hormone pulses in women with weight loss-related amenorrhoea and multifollicular ovaries. Clin Endocrinol (Oxf) (1988) 0.84
5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J Clin Endocrinol Metab (1996) 0.84
Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries. Hum Reprod (2013) 0.83
Assays for prolactin: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem (1986) 0.83
Potent inhibition of human ovarian steroidogenesis by insulin-like growth factor binding protein-4 (IGFBP-4). J Clin Endocrinol Metab (1998) 0.83
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1995) 0.83
Modulation of the insulin-like growth factor-binding proteins by follicle size in the human ovary. J Endocrinol (1997) 0.83